NOV 15, 2018 6:00 AM CET

HDV, the most severe form of viral hepatitis. What you need to know about it

Sponsored by: DiaSorin
Speakers
  • Associate Professor of Virology at the Department of Experimental Medicine and Surgery, University of Rome "Tor Vergata", Italy
    BIOGRAPHY
  • Head of the Hepatitis Unit at the Spanish National Center of Microbiology, Istituto de Salud Carlos III Madrid, Spain
    BIOGRAPHY

Abstract
DATE: November 15, 2018
TIME: 06:00am PST, 09:00am EST, 3:00pm CET
 
Part 1 - Presented by Valentina Svicher
 
Hepatitis Delta Virus: insights and emerging concepts into a peculiar pathogen
Hepatitis D virus (HDV) is a unique RNA virus that requires the hepatitis B surface antigen (HBsAg) to infect the hepatocytes. Chronic Hepatitis D is recognized as the most severe form of viral hepatitis, leading to accelerated progression of cirrhosis and hepatocellular carcinoma and a high mortality rate. HDV infection affects an estimated 15–20 million individuals, is spread worldwide and is endemic in some regions. Moreover, HDV prevalence is increasing in many countries as a consequence of immigration from highly endemic geographic areas.
 
Despite the severity of hepatitis D, screening and treatment has been often neglected in part due to the lack of an effective therapy.  Indeed, interferon alpha is the only anti-HDV drug approved for the treatment of chronic hepatitis D, even if its efficacy is limited and side effects can be severe. Future therapeutic options are under investigation targeting HDV entry, HBsAg secretion, and viral assembly. This webinar will summarize current knowledge on virological and epidemiological aspects of HDV infection with particular attention of categories of individuals in which HDV testing should be prioritized. It also provides an overview on the upcoming treatment options against this virus.
 
Learning Objectives:
  • Discuss epidemiological and virological aspects of HDV infection
  • Identify categories of individuals at risk of acquiring HDV infection
  • Describe current and future HDV treatments
 
 
Part 2 - Presented by Ana Avellon
 
HDV infection: how and when to diagnose a forgotten disease 
Although the most aggressive infectious liver disease, hepatitis delta virus (HDV) infection may be underdiagnosed both for the unawareness or the unavailability of accurate diagnostic methods. Any hepatitis B virus (HBV) infected patient is susceptible to HDV infection for life and consequently searching for HDV should be included in HBV infected patient monitoring guidelines. Periodically detection of HDV antibody and viral RNA in HBV infected patients can early diagnose HDV and may impact the progress of the liver disease.
 
Learning Objectives:
  • How to diagnose HDV: methods and interpretation of results
  • When to ask for HDV diagnosis: guidelines review

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
NOV 15, 2018 6:00 AM CET

HDV, the most severe form of viral hepatitis. What you need to know about it

Sponsored by: DiaSorin


Show Resources
Loading Comments...
Show Resources